Does SECUKINUMAB Cause Dermatitis bullous? 18 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Dermatitis bullous have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.0% of all adverse event reports for SECUKINUMAB.
18
Reports of Dermatitis bullous with SECUKINUMAB
0.0%
of all SECUKINUMAB reports
1
Deaths
7
Hospitalizations
How Dangerous Is Dermatitis bullous From SECUKINUMAB?
Of the 18 reports, 1 (5.6%) resulted in death, 7 (38.9%) required hospitalization.
Is Dermatitis bullous Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Dermatitis bullous?
LINAGLIPTIN (275)
ACETAMINOPHEN (157)
IBUPROFEN (142)
FUROSEMIDE (140)
PEMBROLIZUMAB (136)
METHOTREXATE (129)
VANCOMYCIN (115)
CARBOPLATIN (105)
ESOMEPRAZOLE (103)
NIVOLUMAB (103)
Which SECUKINUMAB Alternatives Have Lower Dermatitis bullous Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG